Spire Cambridge Lea Hospital has invested in some new eye laser equipment to compliment the wide range of treatments it offers for private Ophthalmic patients. Patients will now be able to benefit from less invasive alternatives to surgery with some of the region’s leading ophthalmic surgeons.
Eye surgeons at the Spire Cambridge Lea Hospital are now able to offer laser therapy in outpatients for a variety of common retinal conditions. SLT, Selective Laser Trabeculoplasty is outpatient laser therapy used to treat glaucoma.
The new addition to the existing wide range of ophthalmic technology at The Cambridge Eye Diagnostic Centre at the Spire Cambridge Lea Hospital means that patients can have a less invasive treatment for glaucoma as an alternative to surgery or drug therapy.
SLT, is a gentle and non-invasive treatment for glaucoma. It is not associated with adverse side effects and is a pain-free carried out in outpatients it is an effective option for most glaucoma patients. It is especially suited to patients who cannot tolerate or are unable to self-administer glaucoma medications. Highly effective, SLT is used as primary treatment for early stages of open angle glaucoma, and can also be used in combination with drug therapy, or as an alternative therapy when drugs fail. It is also a flexible treatment option, because it can be repeated, if necessary, depending on the individual patient's response.